BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 35777919)

  • 1. Harnessing microbial iron chelators to develop innovative therapeutic agents.
    Ribeiro M; Sousa CA; Simões M
    J Adv Res; 2022 Jul; 39():89-101. PubMed ID: 35777919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siderophores: Importance in bacterial pathogenesis and applications in medicine and industry.
    Khasheii B; Mahmoodi P; Mohammadzadeh A
    Microbiol Res; 2021 Sep; 250():126790. PubMed ID: 34098495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial siderophores and their potential applications: a review.
    Saha M; Sarkar S; Sarkar B; Sharma BK; Bhattacharjee S; Tribedi P
    Environ Sci Pollut Res Int; 2016 Mar; 23(5):3984-99. PubMed ID: 25758420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting bacterial iron acquisition: siderophore conjugates.
    Ji C; Juárez-Hernández RE; Miller MJ
    Future Med Chem; 2012 Mar; 4(3):297-313. PubMed ID: 22393938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron should be restricted in acute infection.
    Scott CR; Holbein BE; Lehmann CD
    Front Biosci (Landmark Ed); 2020 Jan; 25(4):673-682. PubMed ID: 31585910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing Iron Acquisition Machinery to Target Enterobacteriaceae.
    Sargun A; Gerner RR; Raffatellu M; Nolan EM
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S307-S313. PubMed ID: 33330928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting human pathogenic bacteria by siderophores: A proteomics review.
    Ferreira D; Seca AML; C G A D; Silva AMS
    J Proteomics; 2016 Aug; 145():153-166. PubMed ID: 27109355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefiderocol: Clinical application and emergence of resistance.
    Wang L; Zhu J; Chen L; Du H
    Drug Resist Updat; 2024 Jan; 72():101034. PubMed ID: 38134561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siderophore-Antibiotic Conjugate Design: New Drugs for Bad Bugs?
    Negash KH; Norris JKS; Hodgkinson JT
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31514464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotechnological Potential of Streptomyces Siderophores as New Antibiotics.
    Terra L; Ratcliffe N; Castro HC; Vicente ACP; Dyson P
    Curr Med Chem; 2021; 28(7):1407-1421. PubMed ID: 32389112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siderophore uptake in bacteria and the battle for iron with the host; a bird's eye view.
    Chu BC; Garcia-Herrero A; Johanson TH; Krewulak KD; Lau CK; Peacock RS; Slavinskaya Z; Vogel HJ
    Biometals; 2010 Aug; 23(4):601-11. PubMed ID: 20596754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present and future of siderophore-based therapeutic and diagnostic approaches in infectious diseases.
    Tonziello G; Caraffa E; Pinchera B; Granata G; Petrosillo N
    Infect Dis Rep; 2019 Sep; 11(2):8208. PubMed ID: 31649808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial Siderophores and Their Potential Applications: A Review.
    Prabhakar PK
    Curr Mol Pharmacol; 2020; 13(4):295-305. PubMed ID: 32418535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefiderocol: A Siderophore Cephalosporin.
    El-Lababidi RM; Rizk JG
    Ann Pharmacother; 2020 Dec; 54(12):1215-1231. PubMed ID: 32522005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake Mechanisms and Regulatory Responses to MECAM- and DOTAM-Based Artificial Siderophores and Their Antibiotic Conjugates in
    Fritsch S; Gasser V; Peukert C; Pinkert L; Kuhn L; Perraud Q; Normant V; Brönstrup M; Schalk IJ
    ACS Infect Dis; 2022 Jun; 8(6):1134-1146. PubMed ID: 35500104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics.
    Page MGP
    Clin Infect Dis; 2019 Nov; 69(Suppl 7):S529-S537. PubMed ID: 31724044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Hydroxy-pyridin-4(1H)-ones as siderophores mediated delivery of isobavachalcone enhances antibacterial activity against pathogenic Pseudomonas aeruginosa.
    Huang YJ; Zhong XL; Zang YP; Yang MH; Lin J; Chen WM
    Eur J Med Chem; 2023 Sep; 257():115454. PubMed ID: 37210837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.
    Wilson BR; Bogdan AR; Miyazawa M; Hashimoto K; Tsuji Y
    Trends Mol Med; 2016 Dec; 22(12):1077-1090. PubMed ID: 27825668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cajaninstilbene acid derivatives conjugated with siderophores of 3-hydroxypyridin-4(1H)-ones as novel antibacterial agents against Gram-negative bacteria based on the Trojan horse strategy.
    Huang YJ; Zang YP; Peng LJ; Yang MH; Lin J; Chen WM
    Eur J Med Chem; 2024 Apr; 269():116339. PubMed ID: 38537513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxamate siderophores: Natural occurrence, chemical synthesis, iron binding affinity and use as Trojan horses against pathogens.
    Al Shaer D; Al Musaimi O; de la Torre BG; Albericio F
    Eur J Med Chem; 2020 Dec; 208():112791. PubMed ID: 32947228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.